Trade Report: Today: Axovant Sciences Ltd. (AXON) Receives Outperform Rating from Robert W. Baird

Today: Axovant Sciences Ltd. (AXON) Receives Outperform Rating from Robert W. Baird

Robert W. Baird reiterated their outperform rating on shares of Axovant Sciences Ltd. (NYSE:AXON) in a report issued on Friday morning. They currently have a $29.00 target price on the stock.

Several other research analysts also recently weighed in on AXON. Piper Jaffray Cos. set a $32.00 price target on shares of Axovant Sciences and gave the stock a buy rating in a research report on Friday, September 23rd. HC Wainwright restated a buy rating on shares of Axovant Sciences in a research report on Tuesday, November 8th. Jefferies Group restated a buy rating and set a $31.00 price target on shares of Axovant Sciences in a research report on Monday, September 26th. Zacks Investment Research downgraded shares of Axovant Sciences from a strong-buy rating to a hold rating in a research report on Tuesday, October 25th. Finally, JMP Securities reaffirmed an outperform rating and set a $36.00 price objective on shares of Axovant Sciences in a research note on Tuesday, August 16th. One research analyst has rated the stock with a sell rating, one has given a hold rating and seven have assigned a buy rating to the company. The company presently has an average rating of Buy and an average target price of $26.33.

Shares of Axovant Sciences (NYSE:AXON) opened at 14.19 on Friday. Axovant Sciences has a 1-year low of $8.86 and a 1-year high of $21.30. The company’s market cap is $1.41 billion. The stock’s 50 day moving average is $13.08 and its 200 day moving average is $13.81.

Hedge funds have recently bought and sold shares of the stock. Wells Fargo & Company MN boosted its position in Axovant Sciences by 1.5% in the third quarter. Wells Fargo & Company MN now owns 8,130 shares of the company’s stock worth $113,000 after buying an additional 117 shares during the last quarter. California State Teachers Retirement System boosted its position in Axovant Sciences by 0.8% in the third quarter. California State Teachers Retirement System now owns 51,649 shares of the company’s stock worth $723,000 after buying an additional 400 shares during the last quarter. Rhumbline Advisers boosted its position in Axovant Sciences by 2.3% in the third quarter. Rhumbline Advisers now owns 21,971 shares of the company’s stock worth $308,000 after buying an additional 500 shares during the last quarter. Opus Point Partners Management LLC boosted its position in Axovant Sciences by 10.9% in the third quarter. Opus Point Partners Management LLC now owns 14,844 shares of the company’s stock worth $208,000 after buying an additional 1,455 shares during the last quarter. Finally, TIAA CREF Investment Management LLC boosted its position in Axovant Sciences by 2.6% in the third quarter. TIAA CREF Investment Management LLC now owns 77,911 shares of the company’s stock worth $1,091,000 after buying an additional 1,984 shares during the last quarter.

Axovant Sciences Company Profile

Related posts

Leave a Comment